November 6, 2019

Crescita Gets FDA Approval for Enhanced Formulation of Pliaglis

The company received approval from the US Food and Drug Administration for the enhanced formulation of its topical treatment Pliaglis.
October 28, 2019

Sundial Announces Cannabis and Hemp Topicals Partnership

Sundial Growers (NASDAQ:SNDL) and Crescita Therapeutics (TSX:CTX,OTC:CRRTF) announced an agreement on Monday (October 28) that gives Sundial the rights to Crescita’s skin...
July 9, 2019

3 Top Pharma Stocks on the TSX Year-to-Date

At the halfway mark of the year, it's time to look back on the top performing pharma stocks on the...
June 6, 2019

VIDEO — US vs. Canada Healthcare Systems: Is One Better?

INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
May 16, 2019

VIDEO Round-Up BBHIC 2019

BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 15, 2019

VIDEO — Crescita Therapeutics CEO: Advancing Pliaglis in Europe

CEO Serge Verreault says a new partnership with Cantabria Labs will bring Pliaglis to Italy, Portugal, France and Spain.
May 15, 2019

Crescita Therapeutics Reports 2019 First Quarter Results

Crescita Therapeutics (TSX:CTX) has reported its financial results for the quarter ended March 31, 2019. As quoted in the press...